tiprankstipranks
Advertisement
Advertisement

Fidia Issues 3 Million New Shares After Bond Conversion in POC Program

Story Highlights
  • Fidia converted three POC bonds into 3,000,000 new shares, lifting capital to €11.0 million and total shares to 77.5 million.
  • The move advances Fidia’s 2026 POC financing, reinforcing its equity base to support ongoing growth in high-performance milling technology.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.

Claim 30% Off TipRanks

Fidia Spa ( (IT:FDA) ) has provided an announcement.

Fidia S.p.A. has issued 3,000,000 new shares to Global Growth Holding Limited following the conversion of three bonds from the fifth tranche of its 2026 reserved convertible bond loan. The conversion, executed at €0.01 per share, brings the company’s share capital to €11,027,761.90 and increases the total number of shares outstanding to 77,542,927, while seven bonds in the same tranche remain subscribed but unconverted.

The transaction marks further progress in the partial execution of the capital increase linked to Fidia’s POC financing program, which has so far been subscribed for a nominal €1,250,000 with €1,180,000 of related capital increase already subscribed. The additional equity strengthens Fidia’s capital structure as it continues to support its growth strategy in high-performance milling technologies, with the new shares admitted directly to trading on the regulated market under the existing prospectus.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of numerical control technology and high-performance integrated milling systems. With over 50 years of experience and around 135 employees, it serves the automotive mould and aerospace sectors, offering solutions that span the entire milling process, including numerical controls, high-speed milling machines and CAM software for complex shapes.

Average Trading Volume: 2,056,765

Technical Sentiment Signal: Strong Sell

Current Market Cap: €585.4K

For detailed information about FDA stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1